Japan Tissue Engineering (7774) · InitiativeRestated
Cell and material development for new products targeting the knee region
First written in FY2024-Q2. 1 of 2 entries say "Restated". Latest entry: FY2024.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Development of new cell- and material-based products for knee treatmentA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2024RestatedAnnual report
「In June 2023, a project related to the development of new products for the knee field was selected under the “New Aichi Creative Research and Development Subsidy” program solicited by Aichi Prefecture, and the company is advancing the development of cells and materials for knee treatment.」
The company continues to develop new products using cells and materials for knee treatment, separately from the expansion of Jack's indications. - FY2024-Q2First statedAnnual report
「In June 2023, a project related to the development of new products for the knee field was selected under the “New Aichi Creative Research and Development Subsidy” program solicited by Aichi Prefecture, and the company is advancing the development of cells and materials for knee treatment.」
Following selection for an Aichi Prefecture subsidy program, the company began developing new products using cells and materials for knee treatment, separately from the expansion of Jack's indications.